Cargando…

How many cores should be taken from each region of interest when performing a targeted transrectal prostate biopsy?

BACKGROUND: The number of core biopsies required per region of interest (ROI) is controversial, as is the localization of the core to be taken from a lesion. This study aimed to determine the ideal biopsy core number and location in a multiparametric magnetic resonance imaging guided targeted prosta...

Descripción completa

Detalles Bibliográficos
Autores principales: Cetin, Serhat, Huseyinli, Arif, Koparal, Murat Yavuz, Bulut, Ender Cem, Ucar, Murat, Gonul, Ipek I., Sozen, Sinan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318326/
https://www.ncbi.nlm.nih.gov/pubmed/37409093
http://dx.doi.org/10.1016/j.prnil.2023.01.003
_version_ 1785068012539215872
author Cetin, Serhat
Huseyinli, Arif
Koparal, Murat Yavuz
Bulut, Ender Cem
Ucar, Murat
Gonul, Ipek I.
Sozen, Sinan
author_facet Cetin, Serhat
Huseyinli, Arif
Koparal, Murat Yavuz
Bulut, Ender Cem
Ucar, Murat
Gonul, Ipek I.
Sozen, Sinan
author_sort Cetin, Serhat
collection PubMed
description BACKGROUND: The number of core biopsies required per region of interest (ROI) is controversial, as is the localization of the core to be taken from a lesion. This study aimed to determine the ideal biopsy core number and location in a multiparametric magnetic resonance imaging guided targeted prostate biopsy (TPB), without reducing the clinically significant prostate cancer (csPC) detection rate. MATERIALS AND METHODS: Data of patients who had PI-RADS ≥3 lesions on multiparametric magnetic resonance imaging and underwent a TPB in our clinic between October 2020 and January 2022 were reviewed, retrospectively. The first and second cores were taken from the central part of the ROI, whereas the third and fourth cores were taken from the right and left peripheries of the ROI. We compared the csPC detection success of single-, 2-, 3-, and 4-core samplings. RESULTS: Software-based transrectal TPB was performed on 251 ROIs in a total of 167 patients. Internal Society of Urological Pathology Grade Group ≥2 cancer was detected in at least one core in 64 (25.4%) lesions. Moreover, csPC was detected in 42 (65.6%) ROIs in first-core biopsies; in 59 (92.2%) ROIs in first- and second-core biopsies; in 62 (96.9%) ROIs in first-, second-, and third-core biopsies; and in 64 (100%) ROIs in first-, second-, third-, and fourth-core biopsies. Using McNemar's test for comparison, a significant difference was found in terms of csPC detection success between performing first-core and second-core biopsies (65.6 – 92.2%, p < 0.001); by contrast, no significant difference was observed in csPC detection success between 2-core and 3-core biopsies (92.2% - 96.9%, p = 0.24). Furthermore, no significant difference existed between performing second-core and fourth-core biopsies in terms of csPC detection success (92.2%–100%, p = 0.07). CONCLUSION: We concluded that taking 2-core biopsies from the center of each ROIs during a transrectal TPB is sufficient for diagnosing csPC.
format Online
Article
Text
id pubmed-10318326
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Asian Pacific Prostate Society
record_format MEDLINE/PubMed
spelling pubmed-103183262023-07-05 How many cores should be taken from each region of interest when performing a targeted transrectal prostate biopsy? Cetin, Serhat Huseyinli, Arif Koparal, Murat Yavuz Bulut, Ender Cem Ucar, Murat Gonul, Ipek I. Sozen, Sinan Prostate Int Research Article BACKGROUND: The number of core biopsies required per region of interest (ROI) is controversial, as is the localization of the core to be taken from a lesion. This study aimed to determine the ideal biopsy core number and location in a multiparametric magnetic resonance imaging guided targeted prostate biopsy (TPB), without reducing the clinically significant prostate cancer (csPC) detection rate. MATERIALS AND METHODS: Data of patients who had PI-RADS ≥3 lesions on multiparametric magnetic resonance imaging and underwent a TPB in our clinic between October 2020 and January 2022 were reviewed, retrospectively. The first and second cores were taken from the central part of the ROI, whereas the third and fourth cores were taken from the right and left peripheries of the ROI. We compared the csPC detection success of single-, 2-, 3-, and 4-core samplings. RESULTS: Software-based transrectal TPB was performed on 251 ROIs in a total of 167 patients. Internal Society of Urological Pathology Grade Group ≥2 cancer was detected in at least one core in 64 (25.4%) lesions. Moreover, csPC was detected in 42 (65.6%) ROIs in first-core biopsies; in 59 (92.2%) ROIs in first- and second-core biopsies; in 62 (96.9%) ROIs in first-, second-, and third-core biopsies; and in 64 (100%) ROIs in first-, second-, third-, and fourth-core biopsies. Using McNemar's test for comparison, a significant difference was found in terms of csPC detection success between performing first-core and second-core biopsies (65.6 – 92.2%, p < 0.001); by contrast, no significant difference was observed in csPC detection success between 2-core and 3-core biopsies (92.2% - 96.9%, p = 0.24). Furthermore, no significant difference existed between performing second-core and fourth-core biopsies in terms of csPC detection success (92.2%–100%, p = 0.07). CONCLUSION: We concluded that taking 2-core biopsies from the center of each ROIs during a transrectal TPB is sufficient for diagnosing csPC. Asian Pacific Prostate Society 2023-06 2023-01-14 /pmc/articles/PMC10318326/ /pubmed/37409093 http://dx.doi.org/10.1016/j.prnil.2023.01.003 Text en © 2023 The Asian Pacific Prostate Society. Published by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Cetin, Serhat
Huseyinli, Arif
Koparal, Murat Yavuz
Bulut, Ender Cem
Ucar, Murat
Gonul, Ipek I.
Sozen, Sinan
How many cores should be taken from each region of interest when performing a targeted transrectal prostate biopsy?
title How many cores should be taken from each region of interest when performing a targeted transrectal prostate biopsy?
title_full How many cores should be taken from each region of interest when performing a targeted transrectal prostate biopsy?
title_fullStr How many cores should be taken from each region of interest when performing a targeted transrectal prostate biopsy?
title_full_unstemmed How many cores should be taken from each region of interest when performing a targeted transrectal prostate biopsy?
title_short How many cores should be taken from each region of interest when performing a targeted transrectal prostate biopsy?
title_sort how many cores should be taken from each region of interest when performing a targeted transrectal prostate biopsy?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318326/
https://www.ncbi.nlm.nih.gov/pubmed/37409093
http://dx.doi.org/10.1016/j.prnil.2023.01.003
work_keys_str_mv AT cetinserhat howmanycoresshouldbetakenfromeachregionofinterestwhenperformingatargetedtransrectalprostatebiopsy
AT huseyinliarif howmanycoresshouldbetakenfromeachregionofinterestwhenperformingatargetedtransrectalprostatebiopsy
AT koparalmuratyavuz howmanycoresshouldbetakenfromeachregionofinterestwhenperformingatargetedtransrectalprostatebiopsy
AT bulutendercem howmanycoresshouldbetakenfromeachregionofinterestwhenperformingatargetedtransrectalprostatebiopsy
AT ucarmurat howmanycoresshouldbetakenfromeachregionofinterestwhenperformingatargetedtransrectalprostatebiopsy
AT gonulipeki howmanycoresshouldbetakenfromeachregionofinterestwhenperformingatargetedtransrectalprostatebiopsy
AT sozensinan howmanycoresshouldbetakenfromeachregionofinterestwhenperformingatargetedtransrectalprostatebiopsy